IRIS
CIPRANDI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.388
AS - Asia 1.498
EU - Europa 1.002
SA - Sud America 247
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.191
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.326
CN - Cina 459
SG - Singapore 452
IE - Irlanda 318
HK - Hong Kong 207
BR - Brasile 195
RU - Federazione Russa 159
VN - Vietnam 157
DE - Germania 130
FI - Finlandia 96
FR - Francia 75
IN - India 61
IT - Italia 54
BD - Bangladesh 48
GB - Regno Unito 40
SE - Svezia 38
CA - Canada 31
ZA - Sudafrica 22
MX - Messico 18
AR - Argentina 17
IQ - Iraq 17
JP - Giappone 17
PL - Polonia 15
PK - Pakistan 14
ID - Indonesia 12
NL - Olanda 12
AT - Austria 9
CO - Colombia 9
EC - Ecuador 9
ES - Italia 9
UA - Ucraina 9
EG - Egitto 8
TR - Turchia 7
VE - Venezuela 7
KE - Kenya 6
SA - Arabia Saudita 6
BE - Belgio 5
CL - Cile 5
LT - Lituania 5
PH - Filippine 5
RS - Serbia 5
UZ - Uzbekistan 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
MA - Marocco 4
IL - Israele 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
MF - Saint Martin 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.191
Salva come PNG Salva come JPEG
Città #
Dublin 318
Ashburn 310
San Jose 284
Chandler 271
Dallas 248
Singapore 247
Hong Kong 206
Beijing 124
Boardman 70
Princeton 66
Helsinki 62
Lauterbourg 60
Lawrence 60
Los Angeles 57
Munich 54
Medford 53
Nanjing 42
Wilmington 40
New York 39
Ho Chi Minh City 38
Shanghai 34
Redondo Beach 32
Turku 30
Dong Ket 28
Hanoi 28
Council Bluffs 26
Ann Arbor 24
Buffalo 24
Santa Clara 23
Nanchang 22
São Paulo 22
Dearborn 21
Changsha 20
Johannesburg 20
Washington 20
Moscow 18
The Dalles 17
Tokyo 17
Hebei 16
Seattle 16
Da Nang 14
Hangzhou 14
Jacksonville 14
Frankfurt am Main 12
Redwood City 12
Tianjin 12
Warsaw 12
London 11
Orem 11
Shenyang 11
San Francisco 10
Boston 9
Brooklyn 9
Nuremberg 9
Toronto 9
Atlanta 8
Brasília 8
Chicago 8
Milan 8
Pune 8
Chennai 7
Montreal 7
Phoenix 7
Stockholm 7
Amsterdam 6
Baghdad 6
Fairfield 6
Lyon 6
Mexico City 6
Rio de Janeiro 6
Brussels 5
Cambridge 5
Charlotte 5
Columbus 5
Delhi 5
Denver 5
Hefei 5
Norwalk 5
Poplar 5
Porto Alegre 5
Thái Nguyên 5
Berlin 4
Bắc Ninh 4
Cairo 4
Falkenstein 4
Haiphong 4
Houston 4
Jakarta 4
Kunming 4
Lahore 4
Las Vegas 4
Manchester 4
Woodbridge 4
Belgrade 3
Campinas 3
Chandigarh 3
City of London 3
Faisalabad 3
Genoa 3
Gunzenhausen 3
Totale 3.504
Salva come PNG Salva come JPEG
Nome #
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 148
Allergen-specific immunoglobulin E and allergic rhinitis severity 141
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 138
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 133
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 130
Asthma endotyping and biomarkers in childhood asthma 127
Phleum pratense molecular pattern across Italy 117
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 115
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 113
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 112
Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery 112
Allergen-specific immunoglobulin E and allergic rhinitis severity 109
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 107
Allergen immunotherapy in children and adolescents with respiratory diseases 106
Antihistamines in children and adolescents: A practical update 103
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 101
Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View 99
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 97
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 95
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 95
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 94
Biomarkers of immunotherapy response in patients with allergic rhinitis 91
Severe asthma in children: Current goals and unmet needs 91
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 90
Asthma control in children and adolescents: a study in clinical practice 87
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 85
Cough Remedies for Children and Adolescents: Current and Future Perspectives 85
Allergy and Otitis Media in Clinical Practice 81
Pentraxin 3 and D-dimer in children with asthma: A real-world study 79
Allergen immunotherapy and asthma 78
Asthma in children and adolescents: The control’asma project 76
Immunotherapy and asthma in children 75
Special Issues for Coronavirus Disease 2019 in Children and Adolescents 74
Anxiety and depression in adolescents with asthma and in their parents: A study in clinical practice 72
Personalized therapies for the treatment of allergic rhinitis 72
Attitude to food supplement use: a survey promoted by the Italian Society of Pediatric Allergy and Immunology 70
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children 69
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors 66
Allergic rhinoconjunctivitis: Pathophysiological mechanism and new therapeutic approach 65
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 64
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach 64
Complementary treatment of allergic rhinoconjunctivitis: The role of the nutraceutical lertal® 63
The relevance of symptom perception in the management of severe asthma in adolescents 63
Foreword 63
Focus on the cetirizine use in clinical practice: a reappraisal 30  years later 60
What are the effects of rhinitis on patients with asthma? 60
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice 59
New approaches for identifying and testing potential new anti-asthma agents 58
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis 58
The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study 57
Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? 56
The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the “ControL'Asma” study 55
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy 54
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough 53
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 53
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 52
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis 51
Vitamin D3 in children with allergic asthma in clinical practice 48
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 47
The relevance of symptom perception in the management of severe asthma in adolescents 47
COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission 46
Cetirizine use in childhood: An update of a friendly 30-year drug 45
Letters to the Editor 42
To prevent the allergic disease: The dream of the allergist 41
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 41
Respiratory infections in allergic children: The preventive role of a multicomponent nutraceutical 39
Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence 32
Totale 5.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022282 1 2 12 6 10 18 5 17 11 11 41 148
2022/2023819 97 49 6 73 52 85 0 39 376 8 27 7
2023/2024410 44 58 38 38 35 105 20 30 2 25 5 10
2024/20251.017 18 74 30 52 22 52 67 43 242 29 143 245
2025/20262.319 189 158 293 194 288 119 492 90 193 131 96 76
Totale 5.269